Logo image of ALNSE.PA

NSE (ALNSE.PA) Stock Fundamental Analysis

EPA:ALNSE - FR0004065639 - Common Stock

38.7 EUR
-0.4 (-1.02%)
Last: 9/3/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, ALNSE scores 6 out of 10 in our fundamental rating. ALNSE was compared to 43 industry peers in the Aerospace & Defense industry. ALNSE is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ALNSE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ALNSE had positive earnings in the past year.
ALNSE had a positive operating cash flow in the past year.
In the past 5 years ALNSE has always been profitable.
ALNSE had a positive operating cash flow in 4 of the past 5 years.
ALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.15%, ALNSE is in the better half of the industry, outperforming 62.79% of the companies in the same industry.
ALNSE has a Return On Equity of 8.69%. This is comparable to the rest of the industry: ALNSE outperforms 46.51% of its industry peers.
ALNSE has a better Return On Invested Capital (10.97%) than 69.77% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALNSE is in line with the industry average of 9.49%.
The last Return On Invested Capital (10.97%) for ALNSE is above the 3 year average (9.24%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.15%
ROE 8.69%
ROIC 10.97%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ALNSE.PA Yearly ROA, ROE, ROICALNSE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

1.3 Margins

ALNSE has a Profit Margin (3.50%) which is comparable to the rest of the industry.
ALNSE's Profit Margin has declined in the last couple of years.
ALNSE has a Operating Margin of 6.85%. This is in the lower half of the industry: ALNSE underperforms 60.47% of its industry peers.
In the last couple of years the Operating Margin of ALNSE has declined.
The Gross Margin of ALNSE (43.87%) is better than 69.77% of its industry peers.
ALNSE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.85%
PM (TTM) 3.5%
GM 43.87%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
ALNSE.PA Yearly Profit, Operating, Gross MarginsALNSE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALNSE is creating some value.
ALNSE has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALNSE has more shares outstanding
Compared to 1 year ago, ALNSE has an improved debt to assets ratio.
ALNSE.PA Yearly Shares OutstandingALNSE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALNSE.PA Yearly Total Debt VS Total AssetsALNSE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 4.17 indicates that ALNSE is not in any danger for bankruptcy at the moment.
The Altman-Z score of ALNSE (4.17) is better than 81.40% of its industry peers.
ALNSE has a debt to FCF ratio of 0.65. This is a very positive value and a sign of high solvency as it would only need 0.65 years to pay back of all of its debts.
ALNSE has a Debt to FCF ratio of 0.65. This is amongst the best in the industry. ALNSE outperforms 93.02% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that ALNSE is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.12, ALNSE belongs to the best of the industry, outperforming 93.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.65
Altman-Z 4.17
ROIC/WACC1.45
WACC7.57%
ALNSE.PA Yearly LT Debt VS Equity VS FCFALNSE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.77 indicates that ALNSE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.77, ALNSE belongs to the top of the industry, outperforming 81.40% of the companies in the same industry.
ALNSE has a Quick Ratio of 1.31. This is a normal value and indicates that ALNSE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALNSE (1.31) is better than 83.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.31
ALNSE.PA Yearly Current Assets VS Current LiabilitesALNSE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

ALNSE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.26%.
ALNSE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.31% yearly.
ALNSE shows a strong growth in Revenue. In the last year, the Revenue has grown by 34.51%.
ALNSE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.37% yearly.
EPS 1Y (TTM)-12.26%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-59.8%
Revenue 1Y (TTM)34.51%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%16.05%

3.2 Future

ALNSE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.23% yearly.
The Revenue is expected to grow by 17.73% on average over the next years. This is quite good.
EPS Next Y25.09%
EPS Next 2Y29.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year33.7%
Revenue Next 2Y17.73%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALNSE.PA Yearly Revenue VS EstimatesALNSE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
ALNSE.PA Yearly EPS VS EstimatesALNSE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 33.95, the valuation of ALNSE can be described as expensive.
Based on the Price/Earnings ratio, ALNSE is valued a bit cheaper than 65.12% of the companies in the same industry.
ALNSE is valuated rather expensively when we compare the Price/Earnings ratio to 26.84, which is the current average of the S&P500 Index.
ALNSE is valuated rather expensively with a Price/Forward Earnings ratio of 20.64.
Based on the Price/Forward Earnings ratio, ALNSE is valued a bit cheaper than 69.77% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.48. ALNSE is around the same levels.
Industry RankSector Rank
PE 33.95
Fwd PE 20.64
ALNSE.PA Price Earnings VS Forward Price EarningsALNSE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALNSE is valued cheaply inside the industry as 90.70% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ALNSE is valued cheaper than 93.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.61
EV/EBITDA 11.3
ALNSE.PA Per share dataALNSE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ALNSE's earnings are expected to grow with 29.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.35
PEG (5Y)N/A
EPS Next 2Y29.23%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.69%, ALNSE is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.25, ALNSE has a dividend in line with its industry peers.
With a Dividend Yield of 0.69, ALNSE pays less dividend than the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 0.69%

5.2 History

On average, the dividend of ALNSE grows each year by 22.60%, which is quite nice.
Dividend Growth(5Y)22.6%
Div Incr Years2
Div Non Decr Years5
ALNSE.PA Yearly Dividends per shareALNSE.PA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

21.90% of the earnings are spent on dividend by ALNSE. This is a low number and sustainable payout ratio.
The dividend of ALNSE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP21.9%
EPS Next 2Y29.23%
EPS Next 3YN/A
ALNSE.PA Yearly Income VS Free CF VS DividendALNSE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M
ALNSE.PA Dividend Payout.ALNSE.PA Dividend Payout, showing the Payout Ratio.ALNSE.PA Dividend Payout.PayoutRetained Earnings

NSE

EPA:ALNSE (9/3/2025, 7:00:00 PM)

38.7

-0.4 (-1.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)07-23 2025-07-23
Earnings (Next)N/A N/A
Inst Owners20.28%
Inst Owner ChangeN/A
Ins Owners64.28%
Ins Owner ChangeN/A
Market Cap130.81M
Analysts40
Price Target51 (31.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.69%
Yearly Dividend0.25
Dividend Growth(5Y)22.6%
DP21.9%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.6%
PT rev (3m)-0.6%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 33.95
Fwd PE 20.64
P/S 1.26
P/FCF 11.61
P/OCF 9.21
P/B 3.13
P/tB 3.57
EV/EBITDA 11.3
EPS(TTM)1.14
EY2.95%
EPS(NY)1.87
Fwd EY4.84%
FCF(TTM)3.33
FCFY8.62%
OCF(TTM)4.2
OCFY10.86%
SpS30.64
BVpS12.35
TBVpS10.83
PEG (NY)1.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.15%
ROE 8.69%
ROCE 14.62%
ROIC 10.97%
ROICexc 15.46%
ROICexgc 18.16%
OM 6.85%
PM (TTM) 3.5%
GM 43.87%
FCFM 10.88%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ROICexc(3y)11.65%
ROICexc(5y)13.8%
ROICexgc(3y)13.37%
ROICexgc(5y)15.81%
ROCE(3y)12.32%
ROCE(5y)14.64%
ROICexcg growth 3Y-2.2%
ROICexcg growth 5Y-7.13%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y-7.79%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
F-Score5
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.65
Debt/EBITDA 0.49
Cap/Depr 86.46%
Cap/Sales 2.83%
Interest Coverage 41.27
Cash Conversion 135.38%
Profit Quality 310.87%
Current Ratio 1.77
Quick Ratio 1.31
Altman-Z 4.17
F-Score5
WACC7.57%
ROIC/WACC1.45
Cap/Depr(3y)97.38%
Cap/Depr(5y)100.98%
Cap/Sales(3y)3.76%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.26%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-59.8%
EPS Next Y25.09%
EPS Next 2Y29.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)34.51%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%16.05%
Revenue Next Year33.7%
Revenue Next 2Y17.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.7%
EBIT growth 3Y3.84%
EBIT growth 5Y-6.03%
EBIT Next Year110.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y363.17%
FCF growth 3Y-2.62%
FCF growth 5Y6.82%
OCF growth 1Y106.8%
OCF growth 3Y-2.36%
OCF growth 5Y8.53%